Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 07, 2016 16:05 ET | Source: Recro Pharma, Inc.

Recro Pharma Presents Clinical Data at PAINWeek 2016

MALVERN, Pa., Sept. 07, 2016 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro” or the “Company”) (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on products for hospital...
September 06, 2016 07:00 ET | Source: Recro Pharma, Inc.

Recro Pharma to Present at the Rodman & Renshaw 18th Annual Global Investment Conference

MALVERN, Pa., Sept. 06, 2016 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on products for hospital and ambulatory care...
August 19, 2016 10:38 ET | Source: Recro Pharma, Inc.

Recro Pharma Announces Closing of Public Offering of Common Stock

MALVERN, Pa., Aug. 19, 2016 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro” or the “Company”) (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on products for hospital...
August 16, 2016 09:00 ET | Source: Recro Pharma, Inc.

Recro Pharma Announces Pricing of Public Offering of Common Stock

MALVERN, Pa., Aug. 16, 2016 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro” or the “Company”) (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on products for hospital...
August 15, 2016 18:05 ET | Source: Recro Pharma, Inc.

Recro Pharma Announces Proposed Public Offering of Common Stock

MALVERN, Pa., Aug. 15, 2016 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro” or the “Company”) (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on products for hospital...
August 11, 2016 07:00 ET | Source: Recro Pharma, Inc.

Recro Pharma Reports Second Quarter 2016 Financial Results

Announced Positive Top-line Results from Pivotal Phase III Trial of IV Meloxicam Following Bunionectomy Surgery Pivotal Phase III Trial of IV Meloxicam in Abdominoplasty Ongoing with Top-line...
July 26, 2016 16:05 ET | Source: Recro Pharma, Inc.

Recro Pharma Reports Positive Top-Line Results from Pivotal Phase III Clinical Trial of IV Meloxicam

IV Meloxicam Achieves Primary Endpoint in First of Two Pivotal Trials Fifteen of Nineteen Secondary Endpoints Also Met Management to Host Conference Call and Webcast Today at 5:00 PM ET ...
July 05, 2016 07:00 ET | Source: Recro Pharma, Inc.

Recro Pharma Appoints Michael Celano as Chief Financial Officer

MALVERN, Pa., July 05, 2016 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company developing multiple non-opioid therapeutics for the...
June 02, 2016 07:00 ET | Source: Societal CDMO, Inc.

Recro Pharma to Present at the Jefferies 2016 Global Healthcare Conference

MALVERN, Pa., June 02, 2016 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on products for hospital and ambulatory care...
May 12, 2016 09:07 ET | Source: Societal CDMO, Inc.

Recro Pharma Reports First Quarter 2016 Financial Results

Enrollment on track in two pivotal Phase III IV meloxicam trials One trial expected to report top-line results by end of Q3; Other trial to report top-line results by end of Q4 Manufacturing...